Showing results (121-130 of 153) with videos related to

Sort By:
Pageof 16
Elife|October 1, 2021
HIF1α stabilization in hypoxia is not oxidant-initiatedAmit Kumar, Manisha Vaish, Saravanan S Karuppagounder, et al.
Biochemistry|May 25, 2005
Transglutaminase activity is present in highly purified nonsynaptosomal mouse brain and liver mitochondriaBoris F Krasnikov, Soo-Youl Kim, Stephen J McConoughey, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 22, 2002
Therapeutic effects of cystamine in a murine model of Huntington's diseaseAlpaslan Dedeoglu, James K Kubilus, Thomas M Jeitner, et al.
Chemistry & Biology|June 25, 2011
Development of Neh2-luciferase reporter and its application for high throughput screening and real-time monitoring of Nrf2 activatorsNatalya A Smirnova, Renee E Haskew-Layton, Manuela Basso, et al.
Journal of Molecular Medicine (Berlin, Germany)|November 29, 2007
Harnessing hypoxic adaptation to prevent, treat, and repair strokeRajiv R Ratan, Ambreena Siddiq, Natalya Smirnova, et al.
Neuron|July 15, 2023
2-Deoxyglucose drives plasticity via an adaptive ER stress-ATF4 pathway and elicits stroke recovery and Alzheimer's resilienceAmit Kumar, Saravanan S Karuppagounder, Yingxin Chen, et al.
The Journal of Biological Chemistry|October 7, 2005
Mitochondrial cyclic AMP response element-binding protein (CREB) mediates mitochondrial gene expression and neuronal survivalJunghee Lee, Chun-Hyung Kim, David K Simon, et al.
Acta Neuropathologica|March 5, 2013
Epigenetic regulation of cholinergic receptor M1 (CHRM1) by histone H3K9me3 impairs Ca(2+) signaling in Huntington's diseaseJunghee Lee, Yu Jin Hwang, Jong-Yeon Shin, et al.
Journal of Huntington'S Disease|May 31, 2018
Striatal Mutant Huntingtin Protein Levels Decline with Age in Homozygous Huntington's Disease Knock-In Mouse ModelsNicholas R Franich, Manuela Basso, Emily A André, et al.
Antioxidants & Redox Signaling|July 4, 2012
Targeting Nrf2-mediated gene transcription by extremely potent synthetic triterpenoids attenuate dopaminergic neurotoxicity in the MPTP mouse model of Parkinson's diseaseNavneet Ammal Kaidery, Rebecca Banerjee, Lichuan Yang, et al.
Pageof 16